ArticleFrontiers in oncology2025

Venetoclax combined with ATRA shows promising therapeutic potential for TFG:: RARA variant APL: a case report.

Xianfeng Ouyang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.